In our study, astrocyte-secreted IL-1β increased the proliferation of breast cancer cells both in vitro and in vivo, while inhibition of NLRP3 activation in astrocytes or neutralization of secreted IL-1β prevented astrocyte-induced increased proliferation of TNBC cells in both mouse and human models. Here, IL1B is linked to breast cancer.